TMC278 long-acting injectable (rilpivirine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMC278 long-acting injectable (rilpivirine), covering 2012-11-20 to 2012-11-20. Get the full timeline:
Most recent: Clinical Trial Update: TMC278-TiDP15-C158 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of a Single Dose or Three Successive Doses of Intramuscularly (IM) Injected Long Acting Formulation of TMC278 [Phase 1]